Prohibits the Rhode Island medical assistance program from requiring prior authorization or a step therapy protocol for the coverage of a medication classified as an anticonvulsant or antipsychotic.

Plain-English Summary

This bill would change the rules for Rhode Island's Medicaid program (called the Medical Assistance Program) when it comes to covering certain prescription medications. Specifically, it would ban the program from requiring prior authorization or step therapy for two categories of drugs: anticonvulsants (used to treat epilepsy and seizure disorders) and antipsychotics (used to treat conditions like schizophrenia, bipolar disorder, and other mental health conditions).

To understand why this matters, it helps to know what these terms mean. Prior authorization is when a doctor must get special approval from the insurance program before a patient can receive a prescribed medication — a process that can take days or weeks. Step therapy (sometimes called "fail first") requires patients to try cheaper or alternative medications before the program will cover the one their doctor originally prescribed. Both practices can delay patients from getting the treatment their doctor believes is best for them.

This bill would primarily affect low-income Rhode Islanders enrolled in Medicaid who have epilepsy, seizure disorders, schizophrenia, bipolar disorder, or other conditions requiring these medications. Under this bill, if a doctor prescribes an anticonvulsant or antipsychotic, Medicaid would be required to cover it immediately without these extra administrative hurdles. This could mean faster access to treatment and fewer interruptions in care for vulnerable patients.

The bill has been introduced and referred to the House Finance Committee, where lawmakers will consider its potential costs to the state Medicaid budget alongside its benefits to patients.